Raidium

Raidium has developed the first-ever radiological foundation model, referred to as the 'GPT' of radiology. This new generation of AI will enable the creation of an imaging biomarker factory for both clinical practice and research, embedded into an AI-native platform to tackle the complexity of precision medicine. First intended use is dedicated to clinical trials imaging biomarkers such as RECIST in oncology, before having a full AI-native PACS viewer ready for all radiological workflows.